The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia
Open accessAbstract
Microarray techniques hold great promise for identifying risk factors for schizophrenia (SZ) but have not yet generated widely reproducible results due to methodological differences between studies and the high risk of type I inferential errors. Here we established a protocol for conservative analysis and interpretation of gene expression data from the dorsolateral prefrontal cortex of SZ patients using statistical and bioinformatic methods that limit false positives. We also compared brain gene expression profiles with those from peripheral blood cells of a separate sample of SZ patients to identify disease-associated genes that generalize across tissues and populations and further substantiate the use of gene expression profiling of blood for detecting valid SZ biomarkers. Implementing this systematic approach, we: ( i ) discovered 177 putative SZ risk genes in brain, 28 of which map to linked chromosomal loci; ( ii ) delineated six biological processes and 12 molecular functions that may be particularly disrupted in the illness; ( iii ) identified 123 putative SZ biomarkers in blood, 6 of which ( BTG1 , GSK3A , HLA-DRB1 , HNRPA3 , SELENBP1 , and SFRS1 ) had corresponding differential expression in brain; ( iv ) verified the differential expression of the strongest candidate SZ biomarker ( SELENBP1 ) in blood; and ( v ) demonstrated neuronal and glial expression of SELENBP1 protein in brain. The continued application of this approach in other brain regions and populations should facilitate the discovery of highly reliable and reproducible candidate risk genes and biomarkers for SZ. The identification of valid peripheral biomarkers for SZ may ultimately facilitate early identification, intervention, and prevention efforts as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
GoMiner: a resource for biological interpretation of genomic and proteomic data
Zeeberg, B. R., Feng, W., Wang, G., Wang, M. D., Fojo, A. T., Sunshine, M., Narasimhan, S., Kane, D. W., Reinhold, W. C., Lababidi, S., et al. (2003) · Genome Biology · doi:10.1186/gb-2003-4-4-r28 · Cited by 1,198
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
Self-citationPrabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
Location of a Major Susceptibility Locus for Familial Schizophrenia on Chromosome 1q21-q22
Brzustowicz, L. M., Hodgkinson, K. A., Chow, E. W. C., Honer, W. G., & Bassett, A. S. (2000) · Science · doi:10.1126/science.288.5466.678 · Cited by 516
Dose Response and Dose Equivalence of Antipsychotics
Davis, J. M., & Chen, N. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117422.05703.ae · Cited by 358
Complement components of the innate immune system in health and disease in the CNS
Gasque, P., Dean, Y. D., McGreal, E. P., VanBeek, J., & Morgan, B. P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80302-1 · Cited by 343
Hypofrontality in schizophrenia: a meta‐analysis of functional imaging studies
Hill, K., Mann, L., Laws, K. R., Stephenson, C. M. E., Nimmo‐Smith, I., & McKenna, P. J. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00376.x · Cited by 333
Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K., & Kato, T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001437 · Cited by 331
Tsuang, M. T., Nossova, N., Yager, T., Tsuang, M., Guo, S., Shyu, K. G., Glatt, S. J., & Liew, C. C. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30161 · Cited by 239
Self-citationFaraone, S. V., Seidman, L. J., Kremen, W. S., Toomey, R., Pepple, J. R., & Tsuang, M. T. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00263-2 · Cited by 202
Self-citationSelenium deficiency increases susceptibility to glutamate‐induced excitotoxicity
Savaskan, N. E., Bräuer, A. U., Kühbacher, M., Eyüpoglu, I. Y., Kyriakopoulos, A., Ninnemann, O., Behne, D., & Nitsch, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0067fje · Cited by 176
Kotler, M., Barak, P., Cohen, H., Averbuch, I. E., Grinshpoon, A., Gritsenko, I., Nemanov, L., & Ebstein, R. P. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991215)88:6<628::aid-ajmg10>3.0.co;2-e · Cited by 165
Improving false discovery rate estimation
Pounds, S. B., & Cheng, C. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth160 · Cited by 158
Selenium and Colorectal Adenoma: Results of a Pooled Analysis
Jacobs, E. T., Jiang, R., Alberts, D. S., Greenberg, E. R., Gunter, E. W., Karagas, M. R., Lanza, E., Ratnasinghe, L. D., Reid, M. E., Schatzkin, A. G., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh310 · Cited by 156
Martin, K. J., Graner, E., Li, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041622398 · Cited by 127
Middleton, F. A., Pato, C. N., Gentile, K. L., McGann, L., Brown, A. M., Trauzzi, M., Diab, H. I., Morley, C. P., Medeiros, H., Macedo, A., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30171 · Cited by 116
Controlling false-negative errors in microarray differential expression analysis: a PRIM approach
Cole, S. W., Galić, Z., & Zack, J. A. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg242 · Cited by 110
Zvara, Á., Szekeres, G., Janka, Z., Kelemen, J. Z., Cimmer, C., Sántha, M., & Puskás, L. G. (2005) · Disease Markers · doi:10.1155/2005/275318 · Cited by 90
Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model
Šášik, R., Calvo, E. L., & Corbeil, J. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.12.1633 · Cited by 87
Self-citationAbusaad, I., Mackay, D., Zhao, J., Stanford, P., Collier, D. A., & Everall, I. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990614)408:4<560::aid-cne9>3.0.co;2-p · Cited by 79
Self-citationMicroarray truths and consequences
Sasik, R., Woelk, C., & Corbeil, J. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330001 · Cited by 73
Self-citationBiological markers in mental disorders: Post-mortem studies
Rossor, M. N. (1984) · Journal of Psychiatric Research · doi:10.1016/0022-3956(84)90033-5 · Cited by 14
Cited by
Evaluating the comparability of gene expression in blood and brain
Sullivan, P. F., Fan, C., & Perou, C. M. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30272 · Cited by 580
Ayalew, M., Le-Niculescu, H., Levey, D. F., Jain, N., Changala, B., Patel, S. D., Winiger, E., Breier, A., Shekhar, A., Amdur, R., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.37 · Cited by 397
Self-citationFuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
“Second, although numerous studies have demonstrated that the levels of gene expression in blood change after pharmacotherapy of psychiatric disorders [30,31], it is uncertain whether the methylation profiles of DNA from peripheral blood in humans are affected by antidepressants.”
BackgroundEPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2901 · Cited by 303
Mondelli, V., Cattaneo, A., Murri, M. B., Di Forti, M., Handley, R., Hepgul, N., Miorelli, A., Navari, S., Papadopoulos, A. S., Aitchison, K. J., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06745 · Cited by 303
Metadata
- Authors
- Glatt, S. J., Everall, I. P., Kremen, W. S., Corbeil, J., Šášik, R., Khanlou, N., Han, M., Liew, C.-C., & Tsuang, M. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-10-13
- Volume
- 102
- Issue
- 43
- Pages
- 15533-15538
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2016441589
- Cited by
- 322
- References
- 26
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.